Recent Press Releases

Huntingdon Life Sciences Acquires Harlan Laboratories

HUNTINGDON, England -- Huntingdon Life Sciences announced today that it has acquired Harlan Laboratories. The new company will have two operating divisions: Research Models and Services and Contract...

TrialNetworks Joins the DrugDev Family of Technology-Driven Solutions to Advance the Common Goal of Enabling More Efficient Clinical Trials

Audubon, PA and Newton, Mass. - May 5, 2014 - DrugDev, the industry's largest global network of active clinical trial doctors, today announced its acquisition of TrialNetworks. The award-winning...

WuXi PharmaTech Facilities for Late - and Commercial-Stage Analytical and Stability Testing and Clinical-Trial Materials Manufacturing Pass FDA Audit

SHANGHAI -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today...

COVANCE LAUNCHES NEW BRAND: SOLUTIONS MADE REAL™

PRINCETON, N.J. -- Covance Inc. (NYSE: CVD), the world's most comprehensive drug development company, today announced its new brand, Solutions Made RealTM. This brand strategy more effectively...

Covance Reports First Quarter Net Revenue Growth Of 6.9% To $620 Million, Pro Forma EPS Growth Of 20.1% To $0.90 And Adjusted Net Orders Of $710 Million

PRINCETON, N.J. -- Covance Inc. (NYSE: CVD) today reported results for its first quarter ended March 31, 2014. Net revenue was $620 million, representing 6.9% growth from the first quarter of 2013....

Charles River Laboratories Announces First-Quarter 2014 Results from Continuing Operations

– First-Quarter Sales of $299.4 Million – – First-Quarter GAAP Earnings per Share of $0.67 and Non-GAAP Earnings per Share of $0.82 – – Raises Sales and Non-GAAP EPS...

Quintiles Reports First Quarter 2014 Results

Over $1.0 billion of service revenues representing 8.4% growth; Integrated Healthcare Services segment grew service revenues by 6.0% in the quarter Net new business wins of $1.27 billion...

PAREXEL International Reports Third Quarter Fiscal Year 2014 Results

-- Company increases Fiscal Year 2014 revenue and EPS guidance -- 8.3% year-over-year growth in third quarter consolidated service revenue to $492.4 million -- Gross margin of 34.4%, up 300 basis...

ICON Reports First Quarter 2014

Quarter 1 net revenue increased 10% year on year to $350 million. Income from operations was $43.0 million or 12.3% of revenue. Earnings per share were 57 cents. Gross Business wins were $494...

EDASA Scientific Raises Funds for 5-Year Drug Discovery Program

EDASA Scientific LTD, a Medicinal Chemistry CRO is pleased to announce that in a joint effort with an American-based biotech, they successfully managed to raise government funds for a five-year drug...

Seattle-based Contract Research Organization ReachBio Unveils New Website, Rebrands as ReachBio Research Labs

SEATTLE, April 28, 2014 -- ReachBio LLC announced today that it is extending its trade name and will start doing business as ReachBio Research Labs, effective immediately. As part of this rebranding,...

Sinovac Enters Technology Transfer Agreement with Intravacc to Develop and Commercialize Sabin Inactivated Polio Vaccine (sIPV)

BEIJING -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China that focuses on the research, development, manufacturing and commercialization of vaccines,...

Harlan Laboratories Announces Invenium Pharmacology as Agent for Southeast Asia, Australia and New Zealand

ITINGEN, Switzerland--Harlan Laboratories, Ltd., a privately held provider of general and specialty toxicology services, announces the appointment of Invenium Pharmacology as its exclusive agent for...

Medidata Reports Record First Quarter 2014 Results

Record revenues of $76.6 million, a 21% year-over-year increase Record subscription revenue of $63.8 million, a 26% year-over-year increase Record billings of $90 million, a 43% year-over-year...

Quintiles and Biogen Idec Announce Comprehensive Clinical Development Partnership

RESEARCH TRIANGLE PARK, N.C., Apr 24, 2014 -- Quintiles, the world's largest provider of biopharmaceutical development and commercial outsourcing services, and Biogen Idec have entered into a...

SRI International Announces PDCellX™ Xenograft Tumor Model Services to Accelerate Cancer Drug Research

MENLO PARK, Calif. -- SRI International has announced the availability of its PDCellX™ xenograft tumor model services for testing the activity of potential cancer therapeutics. PDCellX models...

CROMSOURCE Expands European Headquarters - Opens New Office Building

CROMSOURCE, an international full service contract research organization (CRO), today announced the official opening of a new office building in Verona, Italy. "CROMSOURCE continues to grow...

WuXi PharmaTech Announces Management Appointments

Dr. Steve Yang Joins Company as EVP and Chief Operating Officer; Edward Hu Named Chief Investment Officer and Remains Chief Financial Officer SHANGHAI -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a...

Quintiles® Transnational Signs Five Year Agreement for OmniComm Systems'® TrialOne®

Quintiles Automates Global Phase I Clinic Operations With TrialOne FORT LAUDERDALE, FL-- OmniComm Systems, Inc. (OTCQB: OMCM), a global leading provider of clinical data management solutions for...

Theorem Clinical Research Expands Partnership with Medidata Solutions

Theorem Clinical Research Expands Partnership with Medidata Solutions (King of Prussia, PA; April 17, 2014) – Theorem Clinical Research, a leading contract research organization that optimizes...